Schedule 13D ownership disclosure

ANTHERA PHARMACEUTCLS INC

Security class unavailable · CUSIP: 03674U201

Event date: 2014-05-14

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
5.2200%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000947871-14-000330
Form type
SC 13D/A
Filer
Anthera Pharmaceuticals Inc
CIK
CIK 1316175
Filed
May 19, 2014
Reporting period
May 14, 2014
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub